Clinical Trial Update: A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating allogeneic mesenchymal bone marrow cells for ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic Mesenchymal Bone Marrow Cells (mesenchymal stem cells)

Snippet

Sponsor: Stemedica Cell Technologies, Inc. | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED